Document is current
Any future updates will be listed below
-
Authors
Ballegaard, Vibe
Brændstrup, Peter
Pedersen, Karin Kaereby
Kirkby, Nikolai
Stryhn, Anette
Ryder, Lars P.
Gerstoft, Jan
Nielsen, Susanne Dam
- License Information
-
More Information
Article History
Received: 2 October 2017
Accepted: 2 February 2018
First Online: 28 February 2018
Competing Interests
: V.B.: No conflicts of interest. P.B.: Unrestricted research grant from Novartis Denmark paid to his institution. Travel grants from Roche, Celgene, Alexion, Gilead. K.K.P.: No conflicts of interest. N.K.: No conflicts of interest. ASB No conflicts of interest L.P.R.: No conflicts of interest J.G.: Honoraria for consulting and presenting paid to his institution from Gilead, Abbvie, ViiV, B.M.S., M.S.D., Janssen, and Medivir. S.D.N.: Unrestricted research grants from Novo Nordisk Foundation, Lundbeck Foundation, Augustinus Foundation, Rigshospitalet Research Council. Travelling grants from Gilead, M.S.D., B.M.S., and G.S.K./ViiV. Advisory board activity for Gilead and G.S.K./ViiV.
